Question

Will bimagrumab be approved for the treatment of obesity by the FDA or EMA by 2029?

1 comment1

Total Forecasters21

Community Prediction32.6% (26% - 35%)

Make a Prediction

50%

community: 32.6%

Authors:

casens

Opened:

Closes:

Scheduled resolution:

Health & Pandemics

2021-2025 Leaderboard

Food and Drug Administration

Obesity, body mass decrease in the U.S. for the first time in over a decade

Independent•Dec 14, 2024

Ozempic Being Abused, Warns Obesity Doctor

Newsweek•Dec 14, 2024

New study finds first US obesity decline in 10 years. Is Ozempic a leading factor?

USA Today•Dec 17, 2024

Learn more about Metaculus NewsMatch

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

80.8%

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

59.7%

Comments

? comments

Authors:

casens

Opened:

Closes:

Scheduled resolution:

Health & Pandemics

2021-2025 Leaderboard

Food and Drug Administration

Obesity, body mass decrease in the U.S. for the first time in over a decade

Independent•Dec 14, 2024

Ozempic Being Abused, Warns Obesity Doctor

Newsweek•Dec 14, 2024

New study finds first US obesity decline in 10 years. Is Ozempic a leading factor?

USA Today•Dec 17, 2024

Learn more about Metaculus NewsMatch

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

80.8%

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

59.7%

Take Our 🏆Quarterly Cup🏆 Survey

MetaculusM

Will bimagrumab be approved for the treatment of obesity by the FDA or EMA by 2029?

Make a Prediction

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

Comments

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?